X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
general practice / family medicine (6) 6
medicine & public health (6) 6
adolescent (4) 4
adult (4) 4
double-blind method (4) 4
female (4) 4
humans (4) 4
index medicus (4) 4
vaccines (4) 4
young-women (4) 4
adjuvants, immunologic - administration & dosage (3) 3
analysis (3) 3
cancer (3) 3
cervical intraepithelial neoplasia - prevention & control (3) 3
cervical intraepithelial neoplasia - virology (3) 3
hematology, oncology and palliative medicine (3) 3
human papillomavirus 16 - immunology (3) 3
human papillomavirus 18 - immunology (3) 3
human-papillomavirus infection (3) 3
oncology (3) 3
papillomavirus infections (3) 3
papillomavirus infections - prevention & control (3) 3
papillomavirus vaccines - administration & dosage (3) 3
particle vaccine (3) 3
time factors (3) 3
treatment outcome (3) 3
uterine cervical neoplasms - pathology (3) 3
uterine cervical neoplasms - virology (3) 3
young adult (3) 3
adults (2) 2
age factors (2) 2
aluminum hydroxide - administration & dosage (2) 2
asia (2) 2
australia (2) 2
cervical cancer (2) 2
cervical intraepithelial neoplasia - diagnosis (2) 2
cervical intraepithelial neoplasia - pathology (2) 2
cervix (2) 2
clinical trials (2) 2
cross infection (2) 2
dna, viral - analysis (2) 2
double-blind (2) 2
europe (2) 2
gynecology (2) 2
human papillomavirus (2) 2
human papillomavirus 16 - genetics (2) 2
human papillomavirus 18 - genetics (2) 2
intraepithelial neoplasia (2) 2
lipid a - administration & dosage (2) 2
lipid a - analogs & derivatives (2) 2
medical colleges (2) 2
neoplasm grading (2) 2
north america (2) 2
nosocomial infections (2) 2
obstetrics/perinatology (2) 2
oncology, experimental (2) 2
papillomavirus infections - diagnosis (2) 2
papillomavirus infections - virology (2) 2
prevention (2) 2
reproductive medicine (2) 2
research (2) 2
sexually transmitted diseases (2) 2
south america (2) 2
urology (2) 2
uterine cervical neoplasms - diagnosis (2) 2
uterine cervical neoplasms - prevention & control (2) 2
vaccination (2) 2
womens health (2) 2
1945-1989 (1) 1
3111 biomedicine (1) 1
adenocarcinoma (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - prevention & control (1) 1
adenocarcinoma - virology (1) 1
adolescence (1) 1
adolescent women (1) 1
age (1) 1
aged 16-26 years (1) 1
algorithms (1) 1
allemagne politique de l'est (1) 1
alphapapillomavirus (1) 1
anglais (1) 1
antigens, viral - immunology (1) 1
art, israeli (1) 1
aufsatzsammlung (1) 1
aussenpolitische koexistenz (1) 1
broad-spectrum (1) 1
carcinogenesis (1) 1
carcinogènesi (1) 1
carcinoma (1) 1
care and treatment (1) 1
catholic church (1) 1
catholic church. cancellaria apostolica (1) 1
catholic church. history (1) 1
cervix dysplasia (1) 1
cervix uteri - metabolism (1) 1
cervix uteri - pathology (1) 1
cervix uteri - virology (1) 1
chambers english dictionary (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e79260
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 7/2015, Volume 20, Issue 4, pp. 8 - 8
Infektionen mit nicht typisierbaren Haemophilus influenzae (NTHi) haben in der Schwangerschaft eine hohe Morbidität und Mortalität sowohl für die Schwangere... 
General Practice / Family Medicine | Medicine & Public Health | Gynecology | Reproductive Medicine | Urology | Obstetrics/Perinatology
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 4/2015, Volume 20, Issue 2, pp. 14 - 14
Patientinnen mit Autoimmunkrankheiten haben nicht häufiger ein Zervixkarzinom. Auch Immunsuppressiva erhöhen das Zervixkarzinomrisiko nicht — mit einer... 
General Practice / Family Medicine | Medicine & Public Health | Gynecology | Reproductive Medicine | Urology | Obstetrics/Perinatology
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 2/2015, Volume 20, Issue 1, pp. 15 - 15
Klinische Studien belegten die hohe Wirksamkeit der bivalenten HPV-16/18-Vakzine. Nach Einführung des bivalenten Impfstoff in das nationale Impfprogramm in... 
Medicine & Public Health | General Practice / Family Medicine
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 12/2014, Volume 19, Issue 6, pp. 16 - 16
Säuglinge nicht Pertussis-geimpfter Mütter haben das Risiko, in den ersten Lebensmonaten an Pertussis zu erkranken. Seit Jahren wird daher die Impfung für... 
Medicine & Public Health | General Practice / Family Medicine
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 12/2014, Volume 19, Issue 6, pp. 17 - 17
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 10/2014, Volume 19, Issue S1, pp. 21 - 21
Aus verschiedensten Gründen ist sportliche Betätigung empfehlenswert. Auch beim Mammakarzinom kann regelmäßiger Sport die Mortalität senken. 
Medicine & Public Health | General Practice / Family Medicine
Journal Article
1988, [7th ed.] --, ISBN 1852960043, xvi, 1792
Book
2007, La biblioteca di Palazzo Bricherasio, ISBN 9788836608973, 373
Book
1972, Bibliothek des Deutschen Historischen Instituts in Rom, ISBN 9783484800571, Volume Bd. 37, 311
Book
1979, Biblioteca Ayacucho, ISBN 8466000097, Volume 52, xxxi, 324 p. --
Book
1979, Studien zur Politik, ISBN 9783452185129, Volume Bd, 4, ix, 307
Book
International Journal of Mass Spectrometry and Ion Processes, ISSN 0168-1176, 1985, Volume 67, Issue 3, pp. 305 - 306
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.